Adenosine A1 receptor knockout mice develop lethal status epilepticus after experimental traumatic brain injury

Area of Science:

• Neuroscience
• Neuropharmacology
• Traumatic Brain Injury Research

Background:

• Adenosine, acting via A1 receptors, is known to have anticonvulsant properties and can inhibit the progression to status epilepticus (SE).
• Seizures following traumatic brain injury (TBI) are a significant concern and may contribute to the secondary injury cascade.

Purpose of the Study:

• To investigate the hypothesis that endogenous adenosine, mediated by A1 receptors, exerts an antiepileptic effect following experimental TBI.
• To determine the role of A1 receptors in seizure development, progression to SE, and mortality after TBI.

Main Methods:

• Controlled cortical impact (CCI) was used to induce experimental TBI in A1-receptor knockout (ko), heterozygous, and wild-type (wt) mice.
• Seizure activity, SE, mortality, seizure scores (via EEG), and physiological parameters (blood pressure, heart rate, blood gases, hematocrit) were assessed.
• Studies were conducted in both male and female mice to evaluate gender-specific effects.

Main Results:

• Male A1-receptor ko mice exhibited significantly higher seizure incidence (83%) and SE (50%) compared to heterozygotes and wt mice after CCI.
• Seizure scores were twofold higher in ko mice, and SE with lethal sustained activity was uniquely observed in this group.
• Female ko mice showed 100% seizure incidence and 83% SE incidence, significantly higher than heterozygotes and wt controls.

Conclusions:

• The data strongly suggest a critical endogenous anticonvulsant role for adenosine acting at A1 receptors in the early stages following experimental TBI.
• A1 receptor deficiency exacerbates seizure activity and increases mortality risk after TBI, highlighting the neuroprotective potential of adenosine.